Characterizing Guillain-Barré Risk Factors Among Traditional Medicare Beneficiaries.

Area of Science:

• Neurology
• Epidemiology
• Autoimmune Disorders

Background:

• Guillain-Barré Syndrome (GBS) is a rare, severe autoimmune condition impacting peripheral nerves.
• Understanding demographic and clinical factors associated with GBS onset is crucial for early identification and management.
• Previous research highlights infections as triggers, but the role of other comorbidities and socioeconomic factors requires further investigation.

Purpose of the Study:

• To identify demographic and clinical characteristics associated with the onset of Guillain-Barré Syndrome (GBS).
• To investigate the association between preexisting and preceding clinical conditions and GBS incidence.
• To explore the influence of socioeconomic and disability status on GBS occurrence using large-scale claims data.

Main Methods:

• Retrospective case-control study utilizing 2005-2020 Medicare fee-for-service claims data.
• Identified 16,280 incident GBS cases using a validated algorithm, matched 1:1 with controls.
• Employed modified Poisson regressions to analyze associations between GBS onset and clinical conditions (preexisting and preceding within 42 days), adjusting for demographic and socioeconomic variables.

Main Results:

• Preexisting disorders of lipid metabolism (aOR≈1.04) and intestinal infections (aOR≈1.05) were associated with GBS.
• Preceding conditions linked to GBS included lipid metabolism disorders (aOR≈1.05), cognitive disorders (aOR≈1.14), and chronic skin ulcers (aOR≈1.07).
• GBS showed positive associations with Medicare-Medicaid dual eligibility and disability status in both models.

Conclusions:

• Findings suggest potential links between GBS and metabolic, infectious, and cognitive conditions, warranting further mechanistic research.
• The association with dual eligibility and disability status highlights the potential role of socioeconomic and structural factors in GBS.
• Medicare claims data can be a valuable tool for studying the epidemiology of rare conditions like GBS.